CMRX Insider Trading Activity and SEC Form 4 Filings
CMRX insider trading summary
No open-market insider purchases or sales of Chimerix Inc (CMRX) have been reported on SEC Form 4 in the past 12 months.
Latest CMRX insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Feb 13, 2025 | Michael Albert Alrutz | SVP and General Counsel | Sell | $7K (1,600 @ $4.52) |
| Feb 13, 2025 | Michael T. Andriole | President and CEO | Sell | $33K (7,370 @ $4.52) |
| Feb 13, 2025 | Allen S. Melemed | Chief Medical Officer | Sell | $14K (3,065 @ $4.50) |
| Feb 13, 2025 | David Jakeman | VP of Finance and Accounting | Sell | $1K (300 @ $4.53) |
| Feb 13, 2025 | Michelle LaSpaluto | Chief Financial Officer | Sell | $10K (2,260 @ $4.51) |
| Jan 30, 2025 | Michelle LaSpaluto | Chief Financial Officer | Sell | $4K (1,015 @ $4.11) |
| Jan 30, 2025 | David Jakeman | VP of Finance and Accounting | Sell | $11K (2,800 @ $4.10) |
| Jan 30, 2025 | Michael T. Andriole | President and CEO | Sell | $10K (2,350 @ $4.10) |
| Aug 8, 2024 | Michael T. Andriole | President and CEO | Sell | $1K (1,285 @ $0.83) |
| Feb 14, 2024 | Michelle LaSpaluto | Chief Financial Officer | Sell | $2K (1,940 @ $1.04) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.